The recent outbreak of coronavirus disease 2019 (COVID‐19), caused by the Severe Acute
Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) has resulted in a world‐wide …

Viral infections can give rise to a systemic decrease in the total number of lymphocytes in the
blood, referred to as lymphopenia. Lymphopenia may affect the host adaptive immune …

The coronaviral spike is the dominant viral antigen and the target of neutralizing antibodies.
We show that SARS-CoV-2 spike binds biliverdin and bilirubin, the tetrapyrrole products of …

Background The world population is currently at a very high risk of Coronavirus disease-
2019 (COVID-19), caused by the severe acute respiratory syndrome-coronavirus-2 (SARS …

Abstract Background Coronavirus disease 2019 (COVID‐19) is associated with
gastrointestinal and hepatic manifestation in up to one fifth of patients. Severe acute …

Abstract Coronavirus disease 2019 (COVID-19), an infectious disease caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is responsible for the most …

COVID-19, a respiratory viral infection, has affected 388 million individuals worldwide as of
the February 4, 2022. In this review, we have outlined the important liver manifestations of …

Increased concentrations of serum aspartate transaminase (AST) and alanine transaminase
(ALT) are common in COVID‐19 patients. However, their capacity to predict mortality …

Objective: The aim of this study was to observe the liver function recovery of COVID-19
patients after discharge. Patients and Methods: A total of 253 discharged COVID-19 patients …

Abstract Introduction: Coronavirus disease 19 (COVID-19) is the greatest pandemic in
modern history. Laboratory test alterations have been described in COVID-19 patients, but …